Cronos Group Inc. - Common Share (CRON)
2.7500
+0.2100 (8.27%)
NASDAQ · Last Trade: May 11th, 6:56 PM EDT
Cronos Group (NASDAQ:CRON) reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter.
Chairman, President and CEO Mike Gorenstein said Crono
Via MarketBeat · May 11, 2026
Err on the side of caution with this falling knife.
Via The Motley Fool · April 22, 2026
And it's in a cannabis-adjacent sector.
Via The Motley Fool · April 4, 2026
Cronos Group Inc (TSX:CRON) Reports Q4 2025 Revenue Beat, In-Line Earningschartmill.com
Via Chartmill · February 26, 2026
Crypto.com Founder Buys AI.com In Most Expensive Domain Sale Evercryptocom
Via Stocktwits · February 7, 2026
Altria's business is still driven mostly by cigarettes.
Via The Motley Fool · March 31, 2026
If fully permitted, the bank will be able to retain and protect customers' digital assets as a nationally regulated entity.
Via Stocktwits · February 23, 2026
Truth Social filed new Bitcoin, Ether, and Cronos exchange-traded funds (ETFs) proposals as U.S. lawmakers debated the Digital Asset Market CLARITY Act.
Via Stocktwits · February 14, 2026
Wall Street has a very short memory, but you shouldn't ignore this worrying trend at Altria.
Via The Motley Fool · January 10, 2026
As of January 9, 2026, the cannabis sector finds itself at a historic crossroads, caught between the euphoria of federal progress and the harsh reality of market mechanics. Following a landmark Executive Order in late 2025 aimed at accelerating the rescheduling of marijuana, the industry has entered the new year
Via MarketMinute · January 9, 2026
Altria has an attractive 7.4% dividend yield backed by a growing dividend, but there is more for investors to consider.
Via The Motley Fool · January 6, 2026
In a move that has sent shockwaves through the global financial markets, the cannabis sector is currently navigating a period of unprecedented volatility following a landmark regulatory shift. On December 18, 2025, President Donald Trump signed a historic Executive Order directing the Attorney General to expedite the reclassification of marijuana
Via MarketMinute · December 19, 2025
Take a look at how the stock has done in recent years.
Via The Motley Fool · December 18, 2025
Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.
Via The Motley Fool · December 16, 2025
Cannabis stocks TLRY, CRON, OGI, and SNDL log momentum gains even as Congress moves to re-criminalize some hemp-derived THC products.
Via Benzinga · November 14, 2025
Via Benzinga · November 11, 2025
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
Via Benzinga · November 3, 2025
Altria has a large dividend yield, a strong dividend history, and a somewhat problematic business.
Via The Motley Fool · October 9, 2025
As whispers of economic uncertainty grow louder and the specter of a market collapse looms, investors are increasingly searching for safe harbors—assets that can weather the storm and offer stability amidst volatility. In this quest for resilience, Altria Group (NYSE: MO), the tobacco giant, often emerges as a prominent
Via MarketMinute · October 6, 2025
President Trump's social media feed put the markets in a frenzy.
Via The Motley Fool · October 1, 2025
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy.
Via Benzinga · September 29, 2025
Tilray shares rose ~5% after launching three EU-GMP medical cannabis strains in Germany and confirming renewed Nasdaq bid-price compliance.
Via Benzinga · August 28, 2025